What is Low Level Laser Therapy (LLLT)?
Dr Endre Mester discovered low level laser therapy in 1967 when his original intention was to find out if laser could cause cancer. Instead, he was amazed to find that not only did the group of mice with shaved hair and going through low level laser irradiation did not develop cancer, but the hair of the mice grew faster and thicker.
Since then, the use of low level laser therapy has received much attention from the medical community. Currently, there are more than 4,000 research reports on low level laser therapy in medical journals around the world, providing solid data for the efficacy and safety of this therapy. To date, low level laser therapy has evolved into a fairly mature therapeutic/healthcare approach in the treatment of various conditions.
Theory of LLLT
The energy of the low level laser is much lower than that of the laser for surgical procedures. The user does not feel warm or uncomfortable, so it is also called “soft laser” or “cold laser”. The biological effects of low level laser are attributed to its “photobiomodulation” of cells, including: activation of mitochondria (also known as “powerhouse of the cell”), the increase production of intracellular ATP (cell’s source of energy) and the opening of the calcium ion channels. As a result, cells become more active, promoting blood circulation and improving health. The study found that low level laser can regulate a variety of growth factors and cytokines, enhance the function of normal cells such as vascular endothelial cells, and help to maintain the body’s normal physiological activity.
Clinical Application for Low Level Laser Therapy
Through rigourous research, low level lasers are found to be suitable for a range of conditions including osteoarthritis, rheumatoid arthritis, bone strain (carpal canal syndrome, tennis elbow, back pain, etc.), wound healing, ischemic heart disease, ischemic stroke, Alzheimer’s disease (brain degeneration), Parkinson’s disease, etc.; related applications have been supported by various clinical studies.
BeWell Device Impact on Red Blood Cells
Clinically, we can easily observe the efficacy of low level lasers by observing the micro-circulation improvement of microvessels, especially the improvement of red blood cells function. About half of the volume in the blood is occupied by red blood cells. Within the red blood cells, hemoglobin accounts for 95% and is responsible for transporting oxygen from the lungs throughout the body. The blood is transported from the blood vessels and enters through the “microvessels (microcirculation)” and supplies tissues and organs throughout the body. Therefore, with healthy red blood cells and unimpeded micro-circulation, the body’s oxygen and nutrient supply will be sufficient. The average size of a normal RBC has a diameter of 7.6um and thickness of 2um. It is pink colored with bi-concave discs and smooth and round edge which are uniform in size and separated. We can observe the health of the red blood cells with the help of a high-resolution microscope.
Are you aware of any problems with your red blood cells? If you like to observe how our BeWell device can impact on your red blood cells before you purchase online, please contact (+65)9145 5880 for a free appointment at our BeWell Global offices in various countries, with no obligations.